Your session is about to expire
← Back to Search
Behavioral Intervention
Mind Body Intervention for COVID-19 Long Haul Syndrome
N/A
Waitlist Available
Led By Michael Donnino, MD
Research Sponsored by Beth Israel Deaconess Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline 4, 8, 13 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial tests if a mind-body program can help people with long-term COVID symptoms feel better. The program includes classes on understanding pain, reducing sensitivity to it, expressing emotions, and lowering stress. It targets patients who have ongoing symptoms without visible tissue damage.
Eligible Conditions
- Long COVID Syndrome
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline 4, 8, 13 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline 4, 8, 13 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in somatic symptom severity
Secondary study objectives
Average Pain
Brain Fog
Dyspnea
+4 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Mind Body Syndrome Therapy for Long CovidExperimental Treatment1 Intervention
The participants will receive an initial one-on-one interview, followed by 1 to 2 hour biweekly group interactive, educational sessions for 12 weeks. This program also includes a day-long "retreat" at the end of the required course period. Participants will also be provided reading materials to study during the intervention period
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Mind Body Syndrome Therapy for Long Covid
2021
N/A
~30
Find a Location
Who is running the clinical trial?
Beth Israel Deaconess Medical CenterLead Sponsor
859 Previous Clinical Trials
12,932,473 Total Patients Enrolled
Michael Donnino, MDPrincipal Investigator - Beth Israel Deaconess Medical Center
Associated Physicians of Hmfp@Bidmc, Beth Israel Deaconess Medical Center, Cambridge Hospital, The, St. Luke's Hospital of New Bedford
Indiana University School Of Medicine (Medical School)
Henry Ford Hospital (Residency)
7 Previous Clinical Trials
599 Total Patients Enrolled